UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.743

Sortiert nach

Retrospective analysis of estrogen receptor 1 and N‑acetyltransferase gene expression in normal breast tissue, primary breast tumors, and established breast cancer cell lines

International journal of oncology, 2018-08, Vol.53 (2), p.694-702

2018

Volltextzugriff (PDF)

Archbishop Fisher, 1945-1961: Church, State and World

1, 2012

Volltextzugriff (PDF)

N-acetyltransferase metabolism and DNA damage following exposure to 4,4’-oxydianiline in human bronchial epithelial cells

Toxicology letters, 2024-07, Vol.398, p.65-68

2024

Volltextzugriff (PDF)

Functional expression of human arylamine N-acetyltransferase NAT110 and NAT111 alleles: a mini review

Pharmacogenetics and genomics, 2018-10, Vol.28 (10), p.238-244

2018

Volltextzugriff (PDF)

N -acetyltransferase 2 haplotype modifies risks for both dyslipidemia and urinary bladder cancer

Pharmacogenetics and genomics, 2023-08, Vol.33 (6), p.136

2023

Volltextzugriff (PDF)

Association between cigarette smoking and ovarian reserve among women seeking fertility care

PloS one, 2022-12, Vol.17 (12), p.e0278998

2022

Volltextzugriff (PDF)

Influence of N‐acetyltransferase polymorphism in the N‐acetylation of asparagine and putrescine

The FASEB journal, 2022-05, Vol.36 (S1), p.n/a

2022

Volltextzugriff (PDF)

N-acetyltransferase SNPs: emerging concepts serve as a paradigm for understanding complexities of personalized medicine

Expert opinion on drug metabolism & toxicology, 2009-04, Vol.5 (4), p.353-366

Hein, David W

2009

Volltextzugriff (PDF)

Effects of dose and human N-acetyltransferase 1 genetic polymorphism in benzidine metabolism and genotoxicity

Archives of toxicology, 2023-06, Vol.97 (6), p.1765-1772

2023

Volltextzugriff (PDF)

Induction of glucose production by heterocyclic amines is dependent on N-acetyltransferase 2 genetic polymorphism in cryopreserved human hepatocytes

Toxicology letters, 2023-07, Vol.383, p.192-195

2023

Volltextzugriff (PDF)

The effect of the rs1799931 G857A (G286E) polymorphism on N-acetyltransferase 2-mediated carcinogen metabolism and genotoxicity differs with heterocyclic amine exposure

Archives of toxicology, 2023-10, Vol.97 (10), p.2697-2705

2023

Volltextzugriff (PDF)

Arylamine N-acetyltransferase acetylation polymorphisms: paradigm for pharmacogenomic-guided therapy- a focused review

Expert opinion on drug metabolism & toxicology, 2021-01, Vol.17 (1), p.9-21

2021

Volltextzugriff (PDF)

Heterocyclic amines reduce insulin-induced AKT phosphorylation and induce gluconeogenic gene expression in human hepatocytes

Archives of toxicology, 2023-06, Vol.97 (6), p.1613-1626

2023

Volltextzugriff (PDF)

Correction: Heterocyclic amines reduce insulin-induced AKT phosphorylation and induce gluconeogenic gene expression in human hepatocytes

Archives of toxicology, 2023-11, Vol.97 (11), p.3019-3019

2023

Volltextzugriff (PDF)

Non-coding and intergenic genetic variants of human arylamine N -acetyltransferase 2 (NAT2) gene are associated with differential plasma lipid and cholesterol levels and cardiometabolic disorders

Frontiers in pharmacology, 2023-04, Vol.14, p.1091976-1091976

2023

Volltextzugriff (PDF)

560G>A (rs4986782) (R187Q) Single Nucleotide Polymorphism in Arylamine N-Acetyltransferase 1 Increases Affinity for the Aromatic Amine Carcinogens 4-Aminobiphenyl and N-Hydroxy-4-Aminobiphenyl: Implications for Cancer Risk Assessment

Frontiers in pharmacology, 2022-02, Vol.13, p.820082

2022

Volltextzugriff (PDF)

Inactivation of GSK-3β by Metallothionein Prevents Diabetes-Related Changes in Cardiac Energy Metabolism, Inflammation, Nitrosative Damage, and Remodeling

Diabetes (New York, N.Y.), 2009-06, Vol.58 (6), p.1391-1402

2009

Volltextzugriff (PDF)

Accuracy of various human NAT2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes

Pharmacogenomics, 2012-01, Vol.13 (1), p.31-41

2012

Volltextzugriff (PDF)

Human N -Acetyltransferase 1 and 2 Differ in Affinity Towards Acetyl-Coenzyme A Cofactor and N -Hydroxy-Arylamine Carcinogens

Frontiers in pharmacology, 2022-02, Vol.13, p.821133-821133

2022

Volltextzugriff (PDF)

Acetyl coenzyme A kinetic studies on N -acetylation of environmental carcinogens by human N -acetyltransferase 1 and its NAT114B variant

Frontiers in pharmacology, 2022-10, Vol.13, p.931323

2022

Volltextzugriff (PDF)

N-acetyltransferase 2 acetylator genotype-dependent N-acetylation of 4-aminobiphenyl in cryopreserved human hepatocytes

Pharmacogenetics and genomics, 2020-04, Vol.30 (3), p.61

2020

Volltextzugriff (PDF)

PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2

Pharmacogenetics and genomics, 2014-08, Vol.24 (8), p.409-425

2014

Volltextzugriff (PDF)

Transcriptional Regulation of Human Arylamine N-Acetyltransferase 2 Gene by Glucose and Insulin in Liver Cancer Cell Lines

Toxicological sciences, 2022-11, Vol.190 (2), p.158-172

2022

Volltextzugriff (PDF)

N-acetyltransferase 2 genetic polymorphism modifies genotoxic and oxidative damage from new psychoactive substances

Archives of toxicology, 2023-01, Vol.97 (1), p.189-199

2023

Volltextzugriff (PDF)

Genetic heterogeneity among slow acetylator N-acetyltransferase 2 phenotypes in cryopreserved human hepatocytes

Archives of toxicology, 2017-07, Vol.91 (7), p.2655-2661

2017

Volltextzugriff (PDF)

1 – 25 von 1.743

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.319)
Mit Volltextzugriff
(1.595)

Publikationsform

6 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(932)
Life Sciences & Biomedicine
(688)
Humans
(490)
Female
(261)
Male
(228)
Animals
(172)
Biological And Medical Sciences
(166)
Middle Aged
(147)
Technology
(134)
Medical Sciences
(128)
Adult
(127)
Arylamine N-Acetyltransferase - Genetics
(123)
Physical Sciences
(118)
Oncology
(117)
Aged
(102)
Acetylation
(91)
Risk Factors
(91)
Pharmacology & Pharmacy
(86)
Computer Science
(84)
Genotype
(82)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Retrospective analysis of estrogen receptor 1 and N‑acetyltransferase gene expression in normal breast tissue, primary breast tumors, and established breast cancer cell lines

Archbishop Fisher, 1945-1961: Church, State and World

N-acetyltransferase metabolism and DNA damage following exposure to 4,4’-oxydianiline in human bronchial epithelial cells

Functional expression of human arylamine N-acetyltransferase NAT110 and NAT111 alleles: a mini review

N -acetyltransferase 2 haplotype modifies risks for both dyslipidemia and urinary bladder cancer

Association between cigarette smoking and ovarian reserve among women seeking fertility care

Influence of N‐acetyltransferase polymorphism in the N‐acetylation of asparagine and putrescine

N-acetyltransferase SNPs: emerging concepts serve as a paradigm for understanding complexities of personalized medicine

Effects of dose and human N-acetyltransferase 1 genetic polymorphism in benzidine metabolism and genotoxicity

Induction of glucose production by heterocyclic amines is dependent on N-acetyltransferase 2 genetic polymorphism in cryopreserved human hepatocytes

The effect of the rs1799931 G857A (G286E) polymorphism on N-acetyltransferase 2-mediated carcinogen metabolism and genotoxicity differs with heterocyclic amine exposure

Arylamine N-acetyltransferase acetylation polymorphisms: paradigm for pharmacogenomic-guided therapy- a focused review

Heterocyclic amines reduce insulin-induced AKT phosphorylation and induce gluconeogenic gene expression in human hepatocytes

Correction: Heterocyclic amines reduce insulin-induced AKT phosphorylation and induce gluconeogenic gene expression in human hepatocytes

Non-coding and intergenic genetic variants of human arylamine N -acetyltransferase 2 (NAT2) gene are associated with differential plasma lipid and cholesterol levels and cardiometabolic disorders

560G>A (rs4986782) (R187Q) Single Nucleotide Polymorphism in Arylamine N-Acetyltransferase 1 Increases Affinity for the Aromatic Amine Carcinogens 4-Aminobiphenyl and N-Hydroxy-4-Aminobiphenyl: Implications for Cancer Risk Assessment

Inactivation of GSK-3β by Metallothionein Prevents Diabetes-Related Changes in Cardiac Energy Metabolism, Inflammation, Nitrosative Damage, and Remodeling

Accuracy of various human NAT2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes

Human N -Acetyltransferase 1 and 2 Differ in Affinity Towards Acetyl-Coenzyme A Cofactor and N -Hydroxy-Arylamine Carcinogens

Acetyl coenzyme A kinetic studies on N -acetylation of environmental carcinogens by human N -acetyltransferase 1 and its NAT114B variant

N-acetyltransferase 2 acetylator genotype-dependent N-acetylation of 4-aminobiphenyl in cryopreserved human hepatocytes

PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2

Transcriptional Regulation of Human Arylamine N-Acetyltransferase 2 Gene by Glucose and Insulin in Liver Cancer Cell Lines

N-acetyltransferase 2 genetic polymorphism modifies genotoxic and oxidative damage from new psychoactive substances

Genetic heterogeneity among slow acetylator N-acetyltransferase 2 phenotypes in cryopreserved human hepatocytes

Suchergebnisse filtern